1. Hollenberg NK, Chenitz WR, Adams DF, Williams GH 1974 Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54(1):34-42
2. Kronenberg HK, Melmed S, Polonsky KS, Larsen PR, eds. 2008 Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders; 505-537
3. Williams JS, Williams GH 2003 50th anniversary of aldosterone. J Clin Endocrinol Metab 88(6):2364-2372
4. Stowasser M 2009 Update in primary aldosteronism. J Clin Endocrinol Metab 94(10):3623-3630
5. Young M, Fullerton M, Dilley R, Funder J 1994 Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93(6):2578-2583
6. Rocha R, Chander PN, Zuckerman A, Stier CT,Jr 1999 Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33(1 Pt 2):232-237
7. Brilla CG, Matsubara LS, Weber KT 1993 Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 71(3):12A-16A
8. Weber KT, Brilla CG 1991 Pathological hypertrophy and cardiac interstitium. fibrosis and renin-angiotensin-aldosterone system. Circulation 83(6):1849-1865
9. Rossi G, Boscaro M, Ronconi V, Funder JW 2005 Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab 16(3):104-107
10. Pessina AC, Sacchetto A, Rossi GP 1997 Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. Adv Exp Med Biol 432:63-69
11. Tsuchiya K, Yoshimoto T, Hirata Y 2009 Endothelial dysfunction is related to aldosterone excess and raised blood pressure. Endocr J 56(4):553-559
12. Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, Ghiadoni L, Bernini M, Santoro G, Salvetti A 2008 Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 26(12):2399-2405
13. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M, Participants of the German Conn's Registry 2009 Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: Results of the german conn's registry. J Clin Endocrinol Metab 94(4):1125-1130
14. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45(8):1243-1248
15. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA 2008 Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168(1):80-85
16. Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C 2009 Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 94(4):1191-1197
17. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P 2006 Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91(2):454-459
18. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF 2009 Fasting plasma glucose and serum lipids in patients with primary aldosteronism: A controlled cross-sectional study. Hypertension 53(4):605-610
19. Anderson GH,Jr, Blakeman N, Streeten DH 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12(5):609-615
20. Gordon RD 1994 Mineralocorticoid hypertension. Lancet 344(8917):240-243
21. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. results in hypertensive patients. Arch Intern Med 141(12):1589-1593
22. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353(9146):40
23. Young WF,Jr, Hogan MJ, Klee GG, Grant CS, van Heerden JA 1990 Primary aldosteronism: Diagnosis and treatment. Mayo Clin Proc 65(1):96-110
24. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48(11):2293-2300
25. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF,Jr 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89(3):1045-1050
26. Safian RD, Textor SC 2001 Renal-artery stenosis. N Engl J Med 344(6):431-442
27. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J 2000 Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85(5):1863-1867
28. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF,Jr, Montori VM, Endocrine Society 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266-3281
29. Litchfield WR, Dluhy RG 1995 Primary aldosteronism. Endocrinol Metab Clin North Am 24(3):593-612
30. Kaplan NM 2004 The current epidemic of primary aldosteronism: Causes and consequences. J Hypertens 22(5):863-869
31. Stewart PM 1999 Mineralocorticoid hypertension. Lancet 353(9161):1341-1347
32. Li JT, Shu SG, Chi CS 1994 Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature. Eur J Pediatr 153(10):715-717
33. Gordon RD, Klemm SA, Tunny TJ, Stowasser M 1992 Primary aldosteronism: Hypertension with a genetic basis. Lancet 340(8812):159-161
34. Meyer A, Brabant G, Behrend M 2005 Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 29(2):155-159
35. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM 1992 A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355(6357):262-265
36. Lifton RP, Dluhy RG, Powers M, Ulick S, Lalouel JM 1992 The molecular basis of glucocorticoid-remediable aldosteronism, a mendelian cause of human hypertension. Trans Assoc Am Physicians 105:64-71
37. New MI 2002 Hypertension in congenital adrenal hyperplasia and apparent mineralocorticoid excess. Ann N Y Acad Sci 970:145-154
38. Quinkler M, Stewart PM 2003 Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 88(6):2384-2392
39. Conn JW, Cohen EL, Lucas CP, McDonald WJ, Mayor GH, Blough WM,Jr, Eveland WC, Bookstein JJ, Lapides J 1972 Primary reninism. hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumors. Arch Intern Med 130(5):682-696
40. Kono T, Ikeda F, Oseko F, Imura H, Tanimura H 1981 Normotensive primary aldosteronism: Report of a case. J Clin Endocrinol Metab 52(5):1009-1013
41. Dluhy RG, Lifton RP 1999 Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 84(12):4341-4344
42. Young WF 2007 Primary aldosteronism: Renaissance of a syndrome. Clin Endocrinol (Oxf) 66(5):607-618
43. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F 2006 Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: Need for a standardized protocol. J Hypertens 24(4):737-745
44. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F, PAPY Study Investigators 2007 Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens 25(7):1433-1442
45. Celen O, O'Brien MJ, Melby JC, Beazley RM 1996 Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131(6):646-650
46. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED,Jr, Sos TA, Atlas SA, Muller FB, Acevedo R, Ulick S, Laragh JH 1994 Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121(11):877-885
47. Nwariaku FE, Miller BS, Auchus R, Holt S, Watumull L, Dolmatch B, Nesbitt S, Vongpatanasin W, Victor R, Wians F, Livingston E, Snyder WH,3rd 2006 Primary hyperaldosteronism: Effect of adrenal vein sampling on surgical outcome. Arch Surg 141(5):497-502; discussion 502-3
48. Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, Hermus AR, Deinum J 2009 Systematic review: Diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 151(5):329-337
49. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA 2004 Role for adrenal venous sampling in primary aldosteronism. Surgery 136(6):1227-1235
50. Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC 2006 Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24(2):371-379
51. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC 2001 Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: Results in 104 consecutive cases. J Clin Endocrinol Metab 86(3):1083-1090
52. Minami I, Yoshimoto T, Hirono Y, Izumiyama H, Doi M, Hirata Y 2008 Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism. Endocr J 55(5):839-846
53. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM,Jr, White CJ, White J, White RA, Antman EM, Smith SC,Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American Association for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease, American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, TransAtlantic Inter-Society Consensus, Vascular Disease Foundation 2006 ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the american association for vascular Surgery/Society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the american association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. Circulation 113(11):e463-654
54. Safian RD 2003 Atherosclerotic renal artery stenosis. Curr Treat Options Cardiovasc Med 5(2):91-101
55. Sfakianakis GN, Bourgoignie JJ, Georgiou M, Guerra JJ,Jr 1993 Diagnosis of renovascular hypertension with ACE inhibition scintigraphy. Radiol Clin North Am 31(4):831-848
56. Nally JV,Jr, Olin JW, Lammert GK 1994 Advances in noninvasive screening for renovascular disease. Cleve Clin J Med 61(5):328-336
57. Setaro JF, Saddler MC, Chen CC, Hoffer PB, Roer DA, Markowitz DM, Meier GH, Gusberg RJ, Black HR 1991 Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 18(3):289-298
58. Streeten DH, Anderson GH,Jr, Wagner S 1990 Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 3(5 Pt 1):360-365
59. Kendrick ML, Curlee K, Lloyd R, Farley DR, Grant CS, Thompson GB, Rowland C, Young WF,Jr, van Heerden JA 2002 Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes. Surgery 132(6):1008-11; discussion 1012
60. Lim PO, Young WF, MacDonald TM 2001 A review of the medical treatment of primary aldosteronism. J Hypertens 19(3):353-361
61. Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI 1972 Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Br Med J 2(5816):729-734
62. Crane MG, Harris JJ 1970 Effect of spironolactone in hypertensive patients. Am J Med Sci 260(6):311-330
63. Jeunemaitre X, Chatellier G, Kreft-Jais C, Charru A, DeVries C, Plouin PF, Corvol P, Menard J 1987 Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60(10):820-825
64. Griffing GT, Cole AG, Aurecchia SA, Sindler BH, Komanicky P, Melby JC 1982 Amiloride in primary hyperaldosteronism. Clin Pharmacol Ther 31(1):56-61
65. McMahon GT, Dluhy RG 2004 Glucocorticoid-remediable aldosteronism. Cardiol Rev 12(1):44-48
66. Edwards MS, Corriere MA 2009 Contemporary management of atherosclerotic renovascular disease. J Vasc Surg 50(5):1197-1210